Bronchopulmonary DysplasiaSymptoms, Doctors, Treatments, Advances & More
Learn About Bronchopulmonary Dysplasia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rubenstein Child Health Building
Dr. J. Michael Collaco is a professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical specialty is pediatric pulmonary medicine, including chronic lung disease of premature infants, lung disease in medically complex patients including ventilators and tracheostomies, hereditary hemorrhagic telangiectasia, aerodigestive disorders, and general pediatric pulmonary conditions. He sees patients inpatient and outpatient at Johns Hopkins (East Baltimore campus), inpatient and outpatient at Mount Washington Pediatric Hospital, and inpatient at Kennedy Krieger Institute. Dr. Collaco attended Yale University for undergraduate studies and received his M.D. and M.S. (Anatomy) from Case Western University School of Medicine in Cleveland, Ohio. He completed his pediatric residency, pediatric pulmonary fellowship, M.B.A., M.P.H., and Ph.D. (Clinical Epidemiology) at the Johns Hopkins University. Dr. Collaco joined the Johns Hopkins faculty in 2008. His primary research interest is in the epidemiology of pediatric respiratory diseases, with a focus on environmental risk factors for cystic fibrosis and bronchopulmonary dysplasia as well as a special interest in the effects of secondhand smoke and electronic cigarette emissions. He has published over 140 peer-reviewed articles. Dr. Collaco is a member of the Cystic Fibrosis Research Development Center and the Hereditary Hemorrhagic Telangiectasia Center of Excellence. He has been recognized by Johns Hopkins with the John C. Hume Scholarship, the Francis F. Schwentker Research Award, and the Robert Dyar Award. Dr. Collaco is a fellow of the American Academy of Pediatrics. Dr. Collaco is rated as an Elite provider by MediFind in the treatment of Bronchopulmonary Dysplasia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Cystic Fibrosis, Pulmonary Hypertension, Pseudomonas Stutzeri Infections, and Gastrostomy. Dr. Collaco is board certified in American Board Of Pediatrics.
Nationwide Children's Hospital
Leif Nelin is a Neonatologist and a Pediatrics provider practicing medicine in Columbus, Ohio. Dr. Nelin is rated as an Elite provider by MediFind in the treatment of Bronchopulmonary Dysplasia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Premature Infant, High Blood Pressure in Infants, Pulmonary Hypertension, and Gastrostomy.
Anne Greenough practices practicing medicine in London, United Kingdom. Ms. Greenough is rated as an Elite expert by MediFind in the treatment of Bronchopulmonary Dysplasia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Bronchopulmonary Dysplasia, Premature Infant, Congenital Diaphragmatic Hernia, Diaphragmatic Hernia, and Endoscopy.
Summary: The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treati...
Summary: It is intended to examine the efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.